{"SPADE_UN_19439": {"Sequence Information": {"Peptide Name": "RGD-Temporin-La [F10S]", "Sequence": "RGDLLRHVVKILSKYL", "Sequence Length": 16, "Biological Activity": ["Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "C4N9P6", "uniprotUrl": "http://www.uniprot.org/uniprot/C4N9P6", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Designed synthetic analogs of the ?-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin ?v?3 homing domain.", "Pubmed ID": "22641352", "Reference": "J Pept Sci. 2012;18:476-486", "Author": "Diao Y, Han W, Zhao H, Zhu S, Liu X, Feng X, Gu J, Yao C, Liu S, Sun C, Pan F", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22641352"}], "Mass": 1910.31, "PI": 10.28, "Net Charge": 4, "Hydrophobicity": 0.13, "Frequent Amino Acids": "LKR", "Absent Amino Acids": "ACEFMNOPQTUW", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 7, "Polar Residues": 9, "Positive Residues": 5, "Negative Residues": 1, "SPADE ID": "SPADE_UN_19439", "Similar Sequences": [{"SPADE_ID": "SPADE_N_05099", "Similarity": 1.0, "Sequence": "MSKLPFEKELKEACSKPTLTQRETALIELVGKLQNALVDSNWDKLIAEQELEYAEERLTSVVWEKRRLERGDL"}, {"SPADE_ID": "SPADE_N_10808", "Similarity": 1.0, "Sequence": "VERIPLVRFKSIKKQLHERGDL"}, {"SPADE_ID": "SPADE_UN_19439", "Similarity": 1.0, "Sequence": "RGDLLRHVVKILSKYL"}], "Hemolytic Activity": "Human hepatocyte cells HL-7702 (L02):38.13±4.19% Inhibition=50 µg/ml,Human embryonic kidney HEK293T cells:32.52±2.28% Inhibition=50 µg/ml,Bovine mammary epithelial cells:29.33±1.39% Inhibition=50 µg/ml,Human PBMC:19.34±2.83% Inhibition=50 µg/ml", "Target Organism": "Human colon adenocarcinoma SW1116(80-90% Inhibition=50µg/ml),Human hepatocarcinoma SMMC-7721(80-90% Inhibition=50µg/ml),Human cervical carcinoma HeLa(70-80% Inhibition=50µg/ml),Human hepatocellular carcinoma HepG2(70-80% Inhibition=50µg/ml),Human gastric cancer BGC-823(70-80% Inhibition=50µg/ml),Human lung carcinoma A549(50-60% Inhibition=50µg/ml)"}}}